by Marisa Meyers | Aug 17, 2023 | Report
Prescriber Perspectives on Weight Loss Drugs in 2023 Examine how healthcare professionals (HCPs) view and prescribe weight loss drugs currently on the market in our new Instant Insights report. Fielded in a single day, this report includes responses from 100 qualified...
by Marisa Meyers | Jun 13, 2023 | Report
Physician Perspectives on the 2023 ASCO Annual Meeting Curious what doctors thought about ASCO? Nearly 100 oncologists and hematologist oncologists shared with us the findings and developments they were most excited about. Check-out our 2023 Post-ASCO report to...
by Marisa Meyers | Jun 13, 2023 | Readout
Adoption of Newly-Approved 1L mNSCLC Regimens Driven by Promotional Activities Promotion plays a major role in the successful launch of a new pharmaceutical product. Companies must develop a marketing strategy that effectively communicates the benefits of the therapy...
by Marisa Meyers | May 18, 2023 | Report
US Patient & Physician Perspectives For this year’s DTC National Conference, InCrowd wanted to demonstrate the ways in which diabetic patients perceive DTC ads for medical devices designed to help treat their condition. We also examined how treating...
by Marisa Meyers | May 11, 2023 | Report
Instant Insights It’s just 3 weeks until ASCO (American Society of Clinical Oncology’s annual meeting), and oncologists have shared with us the agenda topics that most interest them. Immunotherapies topped the list, with CAR-T the most popular among them. Take a look...
by Marisa Meyers | Mar 27, 2023 | Report
A Follow-Up In 2021 an InCrowd study healthcare professionals (HCPs) believed a hybrid approach to pharma communication would dominate post pandemic. 2 years later, with increases in digital communications do the findings hold? Learn more in our follow-up report where...
